Skip to content

Blog

Category: CRO Selection

<a href="https://www.bioagilytix.com/blog/category/uncategorized/">Uncategorized</a>

Women in STEM: Discussing Science with BioAgilytix’s Dr. Jenn Zemo this #WomensHistoryMonth

  • March 26, 2020

As part of Women’s History Month we’d like to highlight a few of the many inspiring women on the BioAgilytix team. First we’ve asked Dr.…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

BioAgilytix Team Q&A: Meet Tatjana Ackermann, Quality Assurance Auditor

  • November 6, 2019

We strive to foster an environment where our team members can continually grow within their role and within the company – not only upwards, but…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

BioAgilytix Team Q&A: Meet Janett Schwarz, Principal Investigator at BioAgilytix

  • October 10, 2019

In our latest Team Q&A, we talk to Janett Schwarz, Principal Investigator at BioAgilytix’s European headquarters, about how her role has evolved since joining our…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

BioAgilytix Team Q&A: Meet Eric Nesbit, Bioanalytical Project Manager/Scientist III

  • September 18, 2019

In this Q&A session we talk with Eric Nesbit, Bioanalytical Project Manager/Scientist III at BioAgilytix, to learn more about what led him to leave his…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

Meet Jelle Hempenius, Business Development Director, Europe

  • September 4, 2019

Did you know that BioAgilytix’s ‘deep bench’ extends beyond those we have working in the lab? Many individuals in our operational departments, from business development…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/cro-selection/">CRO Selection</a>

To the Rescue: Applying a Novel Approach to Minimize False Positive ADA Assay Results

  • July 2, 2019

Target interference can cause false positive ADA assay results and stall out promising drugs. This could have been the case for one study involving an…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

BioAgilytix Team Q&A: Meet Mike Losauro, Senior Business Development Director at BioAgilytix

  • June 20, 2019

Did you know that many of our team members have cross-functional background experience both in the lab and in customer-facing roles, making them uniquely equipped…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

Supporting a Gene Therapy Clinical Trial with Assay to Measure NAbs Against the AAV9 Serotype

  • February 21, 2019

Today we're featuring a case study on how BioAgilytix developed a cell-based assay to determine the prevalence of pre-existing antibodies against the AAV9 serotype in…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

BioAgilytix Partnership Across Continents: Meet William Hunter and Todd Lester

  • October 18, 2018

With headquarters in the USA and Europe, effective team-wide communication is critical to our success. William Hunter, Director of BD & Global Key Accounts at…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

BioAgilytix Team Q&A: Meet Dave Williams, Director, Bioanalytical Operations at BioAgilytix

  • September 26, 2018

In this Team Q&A session, Dave Williams, Director, Bioanalytical Operations at BioAgilytix, talks with us about why he made the move from Kansas City to…

Find Out More